Spinout Active LTD

Company profile

Aramune Technologies Limited

Immunity-boosting compound for animal feed | Aramune Technologies Ltd

Aramune is a natural, plant feed additive that boosts the immune system and natural resistance to bacterial infection in animals and humans.

CRN
NI676055
Founded
2021
Age
5

Overview

Browse spinouts
Legal name
ARAMUNE TECHNOLOGIES LIMITED
Region
Northern Ireland
Registered address
C/O QUBIS LTD
63 UNIVERSITY ROAD
BELFAST
NORTHERN IRELAND
BT7 1NF
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

2 levels 1 ultimate controller
1
Company Active LTD
Aramune Technologies Limited
CRN NI676055
2
Direct controller Active LTD
Qubis Limited
CRN NI017859
3
Ultimate controller
NIC101788
CRN NIC101788

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
5

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

31 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

17 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

01 Feb
2021

Incorporated

Inception

Company registered at Companies House

Spinout profile

4 entries

Company description

Aramune Technologies develops aramune, a immune-boosting compound, for farm animal feed.

Aramune Technologies Ltd (ATL) are developing natural compounds extracted from certain varieties of Mallow plants, which when added to the diet will modulate (rebalance) an animal's immune system, improve its gut microbiome, and help them resist harmful gut bacteria that might cause ill health and compromise performance. The intellectual property upon which the spin-out is based pre-dates this award but our involvement in this project has been helpful in the company's outlook and development.

Project impact

Recently formed company, and has not yet had impact.

The company has built new partnerships with local companies in Northern Ireland, including Devenish. Together they are investing further funds in validating a product for the veterinary supplements market. The company also successfully completed the Innovate UK ICURe programme, and subsequently applied for aid for start-ups funding support from Innovate UK.

Aramune Technologies
2021
Aramune Technologies
2021
Aramune Technologies
2021
ARAMUNE TECHNOLOGIES LIMITED
2021

Public funding

1 award
First funded
2021
Funded years
2021
Age at first award
0 years

Projects

2021 Study Lead participant

The development of a commercially scalable extraction process for Aramune™ a novel plant based immunomodulatory polysaccharide with ICURe substantiated commercial application in animal feed, nutraceutical and pharmaceutical markets

1 Oct 2021 to 31 Mar 2023

Awarded
£297,824
Total cost £297,824

Modern farming systems aim to produce the highest quality food at maximum volume and lowest cost. To achieve these objectives farmers actively manage the health and wellbeing of livestock to reduce disease. Employing modern husbandry techniques, farmers can prevent many diseases and infections that would otherwise cause distress to their animals and compr...

Product types

Study